Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans.
Doroshyenko O, Fuhr U, Kunz D, Frank D, Kinzig M, Jetter A, Reith Y, Lazar A, Taubert D, Kirchheiner J, Baum M, Eisenbrand G, Berger FI, Bertow D, Berkessel A, Sörgel F, Schömig E, Tomalik-Scharte D. Doroshyenko O, et al. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):433-43. doi: 10.1158/1055-9965.EPI-08-0832. Epub 2009 Feb 3. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19190172 Free article.
Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity.
Fuhr U, Boettcher MI, Kinzig-Schippers M, Weyer A, Jetter A, Lazar A, Taubert D, Tomalik-Scharte D, Pournara P, Jakob V, Harlfinger S, Klaassen T, Berkessel A, Angerer J, Sörgel F, Schömig E. Fuhr U, et al. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):266-71. doi: 10.1158/1055-9965.EPI-05-0647. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16492914
Effect of propiverine on cytochrome P450 enzymes: a cocktail interaction study in healthy volunteers.
Tomalik-Scharte D, Jetter A, Kinzig-Schippers M, Skott A, Sörgel F, Klaassen T, Kasel D, Harlfinger S, Doroshyenko O, Frank D, Kirchheiner J, Bräter M, Richter K, Gramatté T, Fuhr U. Tomalik-Scharte D, et al. Drug Metab Dispos. 2005 Dec;33(12):1859-66. doi: 10.1124/dmd.105.005272. Epub 2005 Sep 23. Drug Metab Dispos. 2005. PMID: 16183781 Clinical Trial.
Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric?
Tomalik-Scharte D, Lütjohann D, Doroshyenko O, Frank D, Jetter A, Fuhr U. Tomalik-Scharte D, et al. Clin Pharmacol Ther. 2009 Aug;86(2):147-53. doi: 10.1038/clpt.2009.72. Epub 2009 May 20. Clin Pharmacol Ther. 2009. PMID: 19458613
Cytochrome P450 2C9 phenotyping using low-dose tolbutamide.
Jetter A, Kinzig-Schippers M, Skott A, Lazar A, Tomalik-Scharte D, Kirchheiner J, Walchner-Bonjean M, Hering U, Jakob V, Rodamer M, Jabrane W, Kasel D, Brockmöller J, Fuhr U, Sörgel F. Jetter A, et al. Eur J Clin Pharmacol. 2004 May;60(3):165-71. doi: 10.1007/s00228-004-0754-z. Epub 2004 Mar 25. Eur J Clin Pharmacol. 2004. PMID: 15045499
26 results